How many shares of XENE does Avoro Capital Advisors LLC own?

As of 2026-Q2, Avoro Capital Advisors LLC holds 5.8M shares of XENE (XENON PHARMACEUTICALS INC).

What is Avoro Capital Advisors LLC's XENE position worth?

As of 2026-Q2, Avoro Capital Advisors LLC's XENE position is worth $348.7M.

When did Avoro Capital Advisors LLC first buy XENE?

Based on available 13F filings, Avoro Capital Advisors LLC first reported a position in XENE in 2019-Q1. They have held the position across 30 quarters.

Back to

Avoro Capital Advisors LLC

XENE
30 quarters

Position history for Avoro Capital Advisors LLC's holdings in XENON PHARMACEUTICALS INC

Current Value

$348.7M

Current Shares

5.8M

Total Value Change

+$324.4M

Total Shares Change

+3.4M

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Unchanged	5.8M	0.0%	$348.7M	3.1%	$60.36	0
2026-Q1	Increased	5.8M	+6.5%	$336M	3.3%	$43.79	62
2025-Q4	Increased	5.4M	+0.5%	$243.1M	2.4%	$44.12	54
2025-Q3	Unchanged	5.4M	0.0%	$216.8M	2.8%	$39.06	0
2025-Q2	Decreased	5.4M	-6.0%	$169M	3.0%	$32.40	0
2025-Q1	Increased	5.7M	+1.3%	$192.6M	3.0%	$34.26	58
2024-Q4	Unchanged	5.7M	0.0%	$222.1M	3.1%	$38.53	0
2024-Q3	Unchanged	5.7M	0.0%	$223.1M	3.3%	$38.65	0
2024-Q2	Unchanged	5.7M	0.0%	$220.9M	2.9%	$38.99	0
2024-Q1	Unchanged	5.7M	0.0%	$243.9M	2.8%	$43.05	0
2023-Q4	Increased	5.7M	+15.7%	$261M	3.6%	$46.06	66
2023-Q3	Unchanged	4.9M	0.0%	$167.4M	2.6%	$34.16	0
2023-Q2	Unchanged	4.9M	0.0%	$188.7M	2.6%	$38.43	0
2023-Q1	Unchanged	4.9M	0.0%	$175.4M	2.6%	$35.61	0
2022-Q4	Unchanged	4.9M	0.0%	$193.2M	2.9%	$39.43	0
2022-Q3	Unchanged	4.9M	0.0%	$176.9M	3.3%	$35.89	0
2022-Q2	Decreased	4.9M	-1.7%	$149.1M	2.9%	$30.90	0
2022-Q1	Unchanged	5M	0.0%	$152.4M	2.8%	$30.12	0
2021-Q4	Increased	5M	+36.6%	$155.7M	2.7%	$31.99	69
2021-Q3	Unchanged	3.7M	0.0%	$55.8M	0.9%	$14.86	0
2021-Q2	Unchanged	3.7M	0.0%	$68M	1.2%	$18.05	0
2021-Q1	Increased	3.7M	+30.4%	$65.3M	1.1%	$17.49	60
2020-Q4	Unchanged	2.8M	0.0%	$43.1M	0.7%	$16.04	0
2020-Q3	Unchanged	2.8M	0.0%	$31M	0.4%	$10.83	0
2020-Q2	Increased	2.8M	+1.0%	$35.1M	0.7%	$12.01	42
2020-Q1	Increased	2.8M	+15.5%	$31.4M	1.1%	$10.96	53
2019-Q4	Unchanged	2.4M	0.0%	$31.5M	0.9%	$13.20	0
2019-Q3	Unchanged	2.4M	0.0%	$21.6M	0.9%	$8.77	0
2019-Q2	Unchanged	2.4M	0.0%	$23.7M	0.8%	$9.86	0
2019-Q1	New	2.4M	-	$24.4M	1.1%	$10.16	66

Other major holders of XENE: FMR LLC, BlackRock, Inc.

XENE30 quarters

XENE
30 quarters